March 2022 FDA Recall Drug by Preferred Pharmaceuticals, Inc.
D-0769-2022 - Out of specification results observed in dissolution during long term stability testing.

This Class II drug recall was voluntarily initiated by Preferred Pharmaceuticals, Inc. on March 28, 2022 for the product Drug. The FDA reported the reason for recall as out of specification results observed in dissolution during long term stability testing.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0769-2022

Reason for Recall
Out of specification results observed in dissolution during long term stability testing.
Initiated
03-28-2022
Reported
04-20-2022
Quantity
791 bottles of 90 - Count

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
89950
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Preferred Pharmaceuticals, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA and CA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
05-10-2022
Product Description About Product Description
Full technical description of the product.
Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for Prevacid, 90-Count Bottle, Manufacturer: Dr Reddy's Laboratories Limited, NDC 68788-6390-09

Batch or Lot Expiration Information

Lot# Lots: H0221R, D3021T, D2221J, D1321X, Exp.12/31/2023.